Work Cited Page

Almost Half of Americans Use at Least One Prescription Drug Annual Report on Nation's Health Shows. (2004). Hyattsville, Maryland, US: US Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS Blease, C. (2011). Deception as treatment: The case of depression. Journal Of Medical Ethics: Journal Of The Institute Of Medical Ethics, 37(1), 3-16. doi:10.1136/jme.2010.039313 Dawes, R. M. (1998). 'Listening to Prozac but hearing placebo': Commentary on Kirsch and Saperstein. Prevention & Treatment, 1(2), doi:10.1037/1522-3736.1.1.15c Dunlop, B. W., & Banja, J. J. (2009). A renewed, ethical defense of placebo-controlled trials of new treatments for major depression and anxiety disorders. Journal Of Medical Ethics: Journal Of The Institute Of Medical Ethics, 35(6), 384-389. doi:10.1136/jme.2008.028357 Kirsch, I., Moore, T. J., Scoboria, A., & Nicholls, S. S. (2002). The emperor's new drugs: An analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration. Prevention & Treatment, 5(1), 23. doi:10.1037/1522-3736.5.1.523a Kirsch, I., & Sapirstein, G. (1998). Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication. Prevention & Treatment, 1(2), 2a. doi:10.1037/1522-3736.1.1.12a Littrell, J., & Lacasse, J. R. (2012). Controversies in psychiatry and DSM-5: The relevance for social work (occasional essay). Families In Society, 93(4), 265-269. Littrell, J., & Lacasse, J. R. (2012). The controversy over antidepressant drugs in an era of evidence-based practice. Social Work In Mental Health, 10(6), 445-463. doi:10.1080/15332985.2012.699444 Souery, D., Papakostas, G. I., & Trivedi, M. H. (2006). Treatment-resistant depression. Journal of Clinical Psychiatry, 67, 16.